- Home
- ANSC vs INBX Comparison
ANSC vs INBX Comparison
Compare ANSC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$69.04
Company Overview
Basic Information| Metric | ANSC | INBX |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | United States | United States |
| Employees | N/A | 161 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.0M | 999.7M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | ANSC | INBX |
|---|---|---|
| Price | $11.26 | $69.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.3K | ★ 136.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 649.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $200,000.00 |
| Revenue This Year | N/A | $563.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $55.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.57 | $10.81 |
| 52 Week High | $11.27 | $94.57 |
Technical Indicators
Market Signals| Indicator | ANSC | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 40.74 |
| Support Level | $11.13 | $28.54 |
| Resistance Level | N/A | $85.97 |
| Average True Range (ATR) | 0.02 | 4.31 |
| MACD | 0.00 | -0.65 |
| Stochastic Oscillator | 87.50 | 15.04 |
Price Performance
Historical Comparison ANSC
INBX
About ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.